<DOC>
	<DOCNO>NCT00219089</DOCNO>
	<brief_summary>To demonstrate efficacy safety aliskiren give patient hypertension diabetes mellitus</brief_summary>
	<brief_title>A Clinical Study Evaluate Safety Efficacy Aliskiren Alone Combination With Ramipril Hypertensive , Diabetic Patients .</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Ramipril</mesh_term>
	<criteria>Inclusion Criteria Patients essential hypertension Patients document diagnosis Type 1 Type 2 diabetes mellitus . Patients eligible able participate study Exclusion Criteria Severe hypertension History evidence secondary form hypertension History hypertensive encephalopathy cerebrovascular accident . Other protocoldefined exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2006</verification_date>
	<keyword>Hypertension , aliskiren , blood pressure , diabetes mellitus , ramipril</keyword>
</DOC>